Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754825
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic StrokeShanghai Pharmaceuticals Holding Co., LtdNot Yet RecruitingPhase 2
NCT07754825Not Yet Recruiting
Phase 2
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Isch...Shanghai Pharmaceuticals...
NCT07756450
Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer SurgeryBakirkoy Dr. Sadi Konuk Research and Training HospitalCompleted
NCT07756450Completed
—
Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorect...Bakirkoy Dr. Sadi Konuk R...
NCT07755631
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organization of Southwestern OntarioNot Yet RecruitingNot Applicable
NCT07755631Not Yet Recruiting
Not Applicable
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organiza...
NCT07756385
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)University Hospital Sveti DuhRecruitingNot Applicable
NCT07756385Recruiting
Not Applicable
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs....University Hospital Sveti...
NCT07755020
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial HospitalRecruiting
NCT07755020Recruiting
—
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial Hosp...
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07756372
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions for Patients With a Progressive Collapsing Foot DeformityCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07756372Not Yet Recruiting
Not Applicable
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions fo...Canadian Institutes of He...
NCT07753850
A Phase 2 Study of SL-325 in Crohn's Disease PatientsShattuck Labs, Inc.Not Yet RecruitingPhase 2
NCT07753850Not Yet Recruiting
Phase 2
A Phase 2 Study of SL-325 in Crohn's Disease PatientsShattuck Labs, Inc.
NCT07755462
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibular Syndesmosis With or Without Fixation of the Posterior Fragments in Bimalleolar or Equivalent FracturesGroupe Hospitalier Diaconesses Croix Saint-SimonActive Not RecruitingNot Applicable
NCT07755462Active Not Recruiting
Not Applicable
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibula...Groupe Hospitalier Diacon...
NCT07755397
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorJubilant Therapeutics India LimitedRecruitingPhase 1
NCT07755397Recruiting
Phase 1
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Stud...Jubilant Therapeutics Ind...
NCT07754786
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic DermatitisInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 3
NCT07754786Not Yet Recruiting
Phase 3
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Partic...Innovent Biologics (Suzho...
NCT07754383
Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With Heart-Kidney Non-interaction SyndromeFohow Pharmaceutical GroupNot Yet RecruitingEarly Phase 1
NCT07754383Not Yet Recruiting
Early Phase 1
Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With H...Fohow Pharmaceutical Grou...
NCT07755774
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot TrialKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07755774Not Yet Recruiting
Not Applicable
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental...Karolinska Institutet
NCT07755124
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled TrialWest China HospitalNot Yet RecruitingPhase 1
NCT07755124Not Yet Recruiting
Phase 1
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Tre...West China Hospital
NCT07755280
Predictors of Sleep Quality in Patients Undergoing Open-Heart SurgeryAydin Adnan Menderes UniversityCompleted
NCT07755280Completed
—
Predictors of Sleep Quality in Patients Undergoing Open-Heart SurgeryAydin Adnan Menderes Univ...
NCT07755189Not Yet Recruiting
—
Night Driving After Trifocal Versus Monofocal IOL ImplantationJin Yang
NCT07753837
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University StudentsNational University of Modern LanguagesCompletedNot Applicable
NCT07753837Completed
Not Applicable
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University St...National University of Mo...
NCT07755683
Effect of Daprodustat and Epoetin Alpha on Anemia in Patients Not Undergoing DialysisServices Hospital, LahoreNot Yet RecruitingNot Applicable
NCT07755683Not Yet Recruiting
Not Applicable
Effect of Daprodustat and Epoetin Alpha on Anemia in Patients Not Undergoing Dia...Services Hospital, Lahore
NCT07755202
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory LeukemiaFlorian KuchenbauerNot Yet RecruitingPhase 2
NCT07755202Not Yet Recruiting
Phase 2
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapse...Florian Kuchenbauer
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Phase 31 (5%)
Early Phase 11 (5%)